Centennial Bank’s iShares Biotechnology ETF IBB Stock Holding History

Centennial Bank’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.3K	Hold	75	–	–	﹤0.01%	282
2026 Q1	$12.7K	Hold	75	–	–	﹤0.01%	269
2025 Q4	$12.7K	Hold	75	–	–	0.01%	275
2025 Q3	$10.8K	Hold	75	–	–	﹤0.01%	279
2025 Q2	$9.49K	Hold	75	–	–	﹤0.01%	286
2025 Q1	$9.59K	Hold	75	–	–	﹤0.01%	281
2024 Q4	$9.92K	Hold	75	–	–	﹤0.01%	264
2024 Q3	$10.9K	Hold	75	–	–	0.01%	267
2024 Q2	$10.3K	Sell	75 -2	-3%	-$267	0.01%	267
2024 Q1	$10.6K	Hold	77	–	–	0.01%	269
2023 Q4	$10.5K	Hold	77	–	–	0.01%	268
2023 Q3	$9.42K	Hold	77	–	–	0.01%	264
2023 Q2	$9.78K	Hold	77	–	–	0.01%	267
2023 Q1	$9.95K	Hold	77	–	–	0.01%	267
2022 Q4	$10.1K	Buy	+77	New	+$9.95K	0.01%	281

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Centennial Bank's IBB Position: Q2 2026 in Review

Centennial Bank held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 75 shares worth $14.3K. The position accounts for ﹤0.01% of the portfolio, ranked #282.

Centennial Bank first reported a position in IBB in Q4 2022 and has held it in 15 quarters since. 958 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Centennial Bank held 75 shares of iShares Biotechnology ETF worth $14.3K as of Q2 2026.
Centennial Bank left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up ﹤0.01% of Centennial Bank's portfolio in Q2 2026, its #282 holding.
Centennial Bank first reported a position in iShares Biotechnology ETF in Q4 2022 and has held it in 15 quarters since.
958 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Centennial Bank's 13F filing for Q2 2026, filed 10 Aug 2026.